Physician profile
Harry Shephard
NPI 1669459350
$1,701.40
in general payments reported to CMS, 2019-2025
16 companies · $27.60 in 2025
The $27.60 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $219 · 2020: $67.63 · 2021: $327 · 2022: $256 · 2023: $264 · 2024: $541 · 2025: $27.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $832.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $832.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $815.16 | 2019-2025 | Rinvoq, Skyrizi, Linzess |
| Phathom Pharmaceuticals, INC. | $255.18 | 2024 | Voquezna |
| Qol Medical, LLC | $124.99 | 2021 | |
| Medtronic, INC. | $105.82 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $104.00 | 2023 | Dupixent |
| Janssen Biotech, INC. | $61.76 | 2022-2024 | Stelara, Tremfya |
| Pfizer INC. | $41.87 | 2021-2024 | |
| Allergan, INC. | $38.26 | 2019 | |
| Celgene Corporation | $26.21 | 2024 | Zeposia |
| Amgen INC. | $24.17 | 2022 | |
| Redhill Biopharma INC. | $21.30 | 2020 | |
| Exact Sciences Corporation | $20.93 | 2023 | Cologuard Collection Kit |
| Evoke Pharma, INC. | $18.26 | 2022 | |
| Braintree Laboratories, INC. | $15.50 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.03 | 2024 | Entyvio |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $13.96 | 2025 | Rezdiffra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harry Shephard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.